Caris Life Sciences (CAI) Expands AI Insights Portfolio With Signature to Predict Ovarian Cancer Platinum Resistance

Caris Life Sciences Inc. (NASDAQ:CAI) is one of the best NASDAQ stocks under $30 to buy. On March 16, Caris Life Sciences expanded its Caris AI Insights portfolio with a new AI signature designed to predict early platinum resistance in patients with high-grade serous ovarian cancer/HGSOC. This tool uses the company’s proprietary CodeAI platform to analyze Whole Exome Sequencing/WES, Whole Transcriptome Sequencing/WTS, and clinical data.

The signature aims to provide clinicians with molecular foresight into how long a patient might benefit from standard platinum-based chemotherapy before disease progression. HGSOC is an aggressive cancer often diagnosed at advanced stages, with ~20% to 30% of patients experiencing resistance within 6 months of their first treatment. By generating a risk score and classifying patients as platinum-sensitive or platinum-resistant, this technology helps doctors identify those who may need to transition quickly to alternative therapies.

This is particularly significant following recent FDA approvals for new combination treatments specifically targeting platinum-resistant cases. The ovarian cancer AI signature is currently available upon request via the Caris Molecular Tumor Board Report when using the company’s MI Cancer Seek tissue-based test. This test, which received FDA approval in late 2024, is the first of its kind to offer simultaneous WES and WTS-based molecular profiling.

Caris Life Sciences (CAI) Expands AI Insights Portfolio With Signature to Predict Ovarian Cancer Platinum Resistance

Caris Life Sciences Inc. (NASDAQ:CAI) is a biotech company that provides molecular profiling services and develops & commercializes healthcare solutions using molecular information and AI/ML algorithms.

While we acknowledge the risk and potential of CAI as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than CAI and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years.

Disclosure: None.  Follow Insider Monkey on Google News.